ArticleslgStudy

science

Noribogainalog

Noribogainalog is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Noribogainalog rather than just read about it. In short: Noribogainalog (nor-IBG), also known as 9-hydroxyibogaminalog or as GATC-021, is a drug of the ibogalog family related to noribogaine. It is a simplified analogue of noribogaine.

Noribogainalog — main illustration
Noribogainalog — illustration

Key takeaways

  • Noribogainalog belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Noribogainalog to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Noribogainalog from memory before moving on to harder problems.

Reference excerpt

Noribogainalog (nor-IBG), also known as 9-hydroxyibogaminalog or as GATC-021, is a drug of the ibogalog family related to noribogaine. It is a simplified analogue of noribogaine.

Pharmacology

Pharmacodynamics Noribogainalog acts as a potent serotonin 5-HT2A receptor partial agonist (EC50Tooltip half-maximal effective concentration ≈ 90 nM; EmaxTooltip maximal efficacy = 35–45%). It is also a partial agonist of the serotonin 5-HT6 receptor (Emax = 29%), whereas it is not an agonist of the serotonin 5-HT2B and 5-HT7 receptors. The drug additionally has activity as a dopamine transporter (DAT) chaperone. Noribogainalog does not affect locomotor activity, does not produce the head-twitch response, and does not affect various other physiological and behavioral measures. However, it does produce analgesic effects that can be diminished by the serotonin 5-HT2A receptor antagonist ketanserin. In addition, a subsequent study found that the highest assessed dose produced significant hypolocomotion and that the drug also reduced fentanyl self-administration.

Pharmacokinetics Noribogainalog shows relatively low expected blood–brain barrier permeability.

Chemistry

Synthesis The chemical synthesis of noribogainalog has been described.

Analogues Analogues of noribogainalog include catharanthalog, ibogainalog, ibogaminalog, PNU-22394, tabernanthalog, 4-allyl-6-oxa-noribogainalog, and noribogaine, among others.

History Noribogainalog was first described in the scientific literature by David E. Olson and colleagues by 2021.

See also Ibogalog

References

External links Noribogainalog - Isomer Design

Illustrations

Noribogainalog illustration
Noribogainalog illustration

Worked examples

Example 1 — a first encounter with Noribogainalog

Start with the simplest possible case. Write down what Noribogainalog claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Noribogainalog before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Noribogainalog ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Noribogainalog

In research
Noribogainalog appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Noribogainalog in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Noribogainalog is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT6 agonists, 5-Hydroxytryptamines, Analgesics, so understanding it makes those chapters shorter.
In everyday life
Look for Noribogainalog outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Noribogainalog” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Noribogainalog in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Noribogainalog means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Noribogainalog out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Noribogainalog in simple terms?

Noribogainalog (nor-IBG), also known as 9-hydroxyibogaminalog or as GATC-021, is a drug of the ibogalog family related to noribogaine. It is a simplified analogue of noribogaine.

Why does Noribogainalog matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Noribogainalog?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Noribogainalog.

Tags

  • 5-HT6 agonists
  • 5-Hydroxytryptamines
  • Analgesics
  • Drugs not assigned an ATC code
  • Ibogalogs
  • N,N-Dialkyltryptamines
  • Non-hallucinogenic 5-HT2A receptor agonists
  • Peripherally selective drugs

Keep exploring